-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang Fourth Pharmaceutical Obtains Drug Production Registration Approval for Rosuvastatin Calcium Tablets
Category:
Time：2020-08-20
Recently, Shijiazhuang Fourth Pharmaceutical Co., Ltd. obtained the drug registration certificate for rosuvastatin calcium tablets (10mg) approved by the National Medical Products Administration.
The rosuvastatin calcium tablets (10 mg) approved by Shijiazhuang No. 4 Pharmaceutical were submitted under Category 4 of the chemical drug registration classification and, upon approval, will be deemed to have passed the consistency evaluation.
It is understood that rosuvastatin calcium tablets are primarily used to treat primary hypercholesterolemia or mixed dyslipidemia.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code